Rational use of medicines - An important issue in pharmaceutical policy

Pharmacy World and Science

Volumn 27, Issue 2, 2005, Pages 76-80

  Almarsdóttir, Anna Birna ^a   Traulsen, Janine M ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical pharmacy; Drug utilisation; Medicine management; Pharmaceutical care; Pharmaceutical policy; Rational medicine use

Indexed keywords

NEW DRUG; NON PRESCRIPTION DRUG;

CLINICAL PHARMACY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG MARKETING; DRUG SAFETY; DRUG UTILIZATION; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH PRACTITIONER; HEALTH PROMOTION; HUMAN; MEDICAL ETHICS; PHARMACEUTICAL CARE; PRESCRIPTION; REVIEW;

DRUG UTILIZATION REVIEW; HUMANS; PHARMACEUTICAL SERVICES; POLICY MAKING; TERMINOLOGY;

EID: 19944394231     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-005-3303-7     Document Type: Review

References (29)

1. D Jary J. Jary 1991 Collins Dictionary of Sociology Harper Collins Publishers Glasgow ISBN 0 00434359 X
2. World Health Organization 2001 How to develop and implement a national drug policy 2 World Health Organization Geneva 59 68 ISBN 92 4 154547 X
3. G. Loewenstein 2004 Doctors and drug companies N Engl J Med. 351 18 1885 90
4. LD Spiller WW. Wymer 2001 Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians Health Mark Q. 19 1 91 106
5. D Armstrong H Reyburn R. Jones 1996 A study of general practitioners' reasons for changing their prescribing behaviour BMJ. 312 7036 949 52
6. MI Jones SM Greenfield CP. Bradley 2001 Prescribing new drugs: qualitative study of influences on consultants and general practitioners BMJ. 323 7309 378 81
7. J Avorn M Chen R. Hartley 1982 Scientific versus commercial sources of influence on the prescribing behavior of physicians Am J Med. 1982 73(1 4 8
8. A. Wazana 2000 Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 283 3 373 80
9. B Mintzes ML Barer RL Kravitz K Bassett J Lexchin A Kazanjian RG Evans R Pan SA. Marion 2003 How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA CMAJ. 169 5 405 12
10. Kaiser Family Foundation. National Survey of Physicians Part II: Doctors and Prescription Drugs, 2002. http://www.kff.org/rxdrugs(20020415b-index.cfm
11. Kaiser Family Foundation. Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising, 2001. http://www.kff.org/rxdrugs/3197-index.cfm
12. Anon. Medicines management services - why are they so important? MeReC Bulletin (National Prescribing Centre NHS) 2002; 12(6)
13. The Audit Commission. A Spoonful of Sugar - Medicines Management in NHS Hospitals. London: The Audit Commission, 2001. http://www.audit-commission.gov. uk/Products/NATIONAL-REPORT/E83C8921-6CEA-4b2c-83E7-F80954A80F85/ nrspoonfulsugar.pdf
14. N. Barber 2001 Pharmaceutical care and medicines management - is there a difference? Pharm World Sci. 23 6 210 11
15. ESCP. What is clinical pharmacy? http://www.escpweb.org/site/cms/ contentViewArticle.asp?article=1712 (accessed 22 November 2004)
16. ACCP. Defining Clinical Pharmacy. The ACCP Report 23(2). February 2004. http://www.accp.com/report/rpt0204/art 01.php
17. RL Mikeal TP Brown HL Lazarus MC. Vinson 1975 Quality of pharmaceutical care in hospitals Am J Hosp Pharm. 3 567 74
18. DC Brodie PA Parish JW. Poston 1980 Societal needs for drugs and drug-related services Am J Pharm Educ. 44 276 78
19. CD Hepler LM. Strand 1990 Opportunities and responsibilities in pharmaceutical care Am J Hosp Pharm. 47 533 43
20. RJ Cipolle LM Strand PC. Morley 2004 Pharmaceutical care practice - the clinician's guide 2 McGraw-Hill New York
21. van Mil JWF. Pharmaceutical care - the future of pharmacy. Thesis, Chapter 1. Rijksuniveriteit Groningen, 1998
22. Munroe WP, Dalmady-Israel C. (1998). The community pharmacist's role in disease management and managed care. Int Pharm J. 12(Suppl II)
23. PP. Rioux 2000 Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications Am J Health Syst Pharm. 57 887 901
24. R. March 2000 Pharmacogenomics: the genomics of drug response Yeast. 17 16 21
25. C Condit A Templeton BR Bates JL Bevan TM. Harris 2003 Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons Genet Med. 5 5 385 92
26. AB Almarsdóttir I Björnsdóttir JM. Traulsen 2005 A lay prescription for tailor-made drugs - focus group reflections on pharmacogenomics Health Policy. 71 233 41
27. F. Lichtenberg 1996 Do (more and better) drugs keep people out of hospitals? Am Econ Rev. 86 2 384 8 ABI/INFORM Global
28. DM Cutler M. McClellan 2001 Is technological change in medicine worth it? Health Aff. 20 5 11 30
29. G Ragnarson Tennvall G. Karlson 1998 Cancer treatment in Sweden - costs of drugs, inpatient and outpatient care from 1985 to 1996 and cost effectiveness of new drugs Acta Oncol. 37 5 447 53